Press Releases

Updates arrive automatically.

• Lucid Diagnostics Recognized as a GenomeWeb Best Place to Work for Second Consecutive Year

  

  

  PR08:25:00·4m·Health CarePenny stock

  Lucid Diagnostics Recognized as a GenomeWeb Best Place to Work for Second Consecutive Year

  Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (NASDAQ:PAVM), today announced that it has been named a GenomeWeb 2026 Best Places to Work honoree, marking its second consecutive year in the annual program recognizing top workplaces across the life sciences research, diagnostics and precision medicine sectors. "Our team's shared passion and relentless dedication to preventing esophageal cancer are the foundation of our success," said Shaun O'Neil, President and Chief Operating O

  $LUCD$PAVM
• TKO Announces Launch of Senior Secured Notes Offering

  

  PR08:25:00·4m·Consumer Discretionary

  TKO Announces Launch of Senior Secured Notes Offering

  TKO Group Holdings, Inc. (NYSE:TKO) ("TKO" or the "Company"), a premium sports and entertainment company, today announced the launch of an offering (the "Offering") of $1.0 billion in aggregate principal amount of Senior Secured Notes due 2031 (the "notes") by its indirect subsidiary, TKO Worldwide Holdings, LLC ("TKO Worldwide"). Completion of the Offering is subject to, among other things, pricing and customary closing conditions.TKO Worldwide expects to use the net proceeds from the Offering for general corporate purposes, which may include making distributions to its parent entities to fund share repurchases under TKO’s previously announced share repurchase program, and to pay related fee

  $TKO
• Claritev Corporation Announces Participation in Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

  

  PR08:23:49·5m·Consumer Discretionary

  Claritev Corporation Announces Participation in Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

  Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data, and insights company, today announced that members of its management team will participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on Wednesday, November 11, 2026, in New York, including a presentation at 3:30 p.m. ET. To listen to the webcast, please visit https://investors.claritev.com/. For one-on-one meetings, please contact a representative at the host firm. About Claritev Claritev is a healthcare technology, data, and insights company focused on delivering affordability, transparency, and quality across the U.S

  $CTEV
• Avery Dennison Announces Cash Tender Offer for Its Senior Notes

  

  PR08:21:00·8m·Consumer Discretionary

  Avery Dennison Announces Cash Tender Offer for Its Senior Notes

  Avery Dennison Corporation (NYSE:AVY), a leading global materials science and digital identification solutions company, today announced that it has commenced tender offers to purchase for cash its debt securities referred to below (collectively, the "Notes," and each a "Series"), in each case upon the terms and subject to the conditions set forth in the Offer to Purchase dated November 5, 2026 (the "Offer to Purchase"). Series of Notes CUSIP/ISIN Number(1) Aggregate Principal Amount Outstanding Acceptance Priority Level(2) Par Call Date Maturity Date Reference Security Bloomberg Reference Page Fixed Spread (Basis Points) 5.750% Senior

  $AVY
• SCYNEXIS Reports Third Quarter 2026 Financial Results and Provides Corporate Update

  

  PR08:20:00·9m·Health CareLow floatPenny stock

  SCYNEXIS Reports Third Quarter 2026 Financial Results and Provides Corporate Update

  Completed Phase 1 study of SCY-770, a first-in-class, highly selective, oral direct AMPK activator for the treatment of ADPKD; Phase 2 proof-of-concept trial to initiate in Q4 2026Awarded BARDA contract providing up to approximately $214 million in non-dilutive funding for the development of SCY-247, including approximately $18.5 million in the initial base period to advance oral and intravenous SCY-247 into a Phase 2 study in invasive candidiasisCompleted Phase 1 study of IV SCY-247; Phase 2 study with both oral and intravenous formulations planned for 2027Strengthened leadership team with the appointments of Sanjay Subramanian as Chief Financial Officer, and Todd Minga, M.D., as Senior Vic

  $SCYX
• Credit Access Expands as Lenders Pair Growth with More Strategic Risk Management

  

  PR08:17:00·12m·Finance

  Credit Access Expands as Lenders Pair Growth with More Strategic Risk Management

  TransUnion’s (NYSE:TRU) newly released Q3 2026 Credit Industry Insights Report (CIIR) found that credit card and unsecured personal loan (UPL) lenders expanded lending over the past year while increasing the share of new accounts opened by riskier borrowers with below-prime credit scores. Despite that expansion, strategic risk mitigation helped lenders reduce delinquent balances across their portfolios. Following a period of rapid growth, the credit market has settled into a more consistent expansion pattern. Total outstanding balances grew by roughly 3% year-over-year (YoY) in Q3 2026 as the number of credit-active consumers reached 263 million.

  $TRU
• NREF Announces Third Quarter 2026 Results, Provides Fourth Quarter 2026 Guidance

  

  PR08:15:00·14m·Real Estate

  NREF Announces Third Quarter 2026 Results, Provides Fourth Quarter 2026 Guidance

  NexPoint Real Estate Finance, Inc. ("NREF" or the "Company") (NYSE:NREF) today reported its financial results for the quarter ended September 30, 2026. NREF reported net loss attributable to common stockholders of $12.2 million, or $0.65 per diluted share1, for the three months ended September 30, 2026.NREF reported cash available for distribution2 of $14.0 million, or $0.60 per diluted common share2, for the three months ended September 30, 2026."Our third quarter results reflect the consistency of the strategy we've outlined for investors: earnings that covered our dividend and a portfolio focused on sectors with durable

  $NREF
• The RealReal Appoints Shar Dubey to Board of Directors

  

  PR08:15:00·14m·Consumer DiscretionaryHigh short interest

  The RealReal Appoints Shar Dubey to Board of Directors

  Former Match Group CEO Brings Deep Expertise in Technology, Digital Consumer

  $REAL
• ADP Canada Pay Insights: Pay for Job-Stayers Was Up 3.0% in October

  

  PR08:15:00·14m·Technology

  ADP Canada Pay Insights: Pay for Job-Stayers Was Up 3.0% in October

  Base pay for job-stayers in Canada increased 3.0% year-over-year in October; pay for job-changers rose 6.0%, according to the October ADP Canada Pay Insights produced by ADP Research. Gross pay for job-stayers increased 4.5%. Gross pay for job-changers increased 10.4%. Drawing on the anonymized payroll transaction data of approximately 1.6 million Canadian workers each month, ADP Canada Pay Insights provides a robust measure of pay trends for job-stayers and job-changers working in Canada's private sector. Using a unique matched sample to track individual workers over a 12-month

  $ADP
• Holley Reports Third Quarter 2026 Results

  

  PR08:15:00·14m·Consumer DiscretionaryPenny stock

  Holley Reports Third Quarter 2026 Results

  CONTINUED NET SALES GROWTH AND MARGIN EXPANSION DRIVE STRONG CASH GENERATION $25 MILLION OF DEBT PREPAID IN THE QUARTER LOWEST LEVERAGE IN FOUR YEARS, YEAR-END TARGET OF 3.5X ACHIEVED A QUARTER EARLY Disciplined Execution Drives Margin Expansion, Stronger

  $HLLY
• Inuvo to Host Third Quarter 2026 Financial Results Conference Call on Thursday, November 12th at 4:15 P.M. ET

  

  PR08:15:00·14m·Consumer DiscretionaryPenny stock

  Inuvo to Host Third Quarter 2026 Financial Results Conference Call on Thursday, November 12th at 4:15 P.M. ET

  Inuvo, Inc. (NYSE:INUV), a provider of artificial intelligence-driven advertising technology, will host a conference call on Thursday, November 12, 2026, at 4:15 p.m. Eastern Time to discuss its financial results and provide a business update for the third quarter ended September 30, 2026. Conference Call Details: Date: Thursday, November 12, 2026Time: 4:15 p.m. Eastern Time Toll-free Dial-in Number: 1-800-717-1738International Dial-in Number: 1-646-307-1865Conference ID: 1122251Webcast Link: https://viavid.webcasts.com/starthere.jsp?ei=1777035&tp_key=f5a1b88357 A telephone replay will be available through Thursday, December 3, 2026.

  $INUV
• Hertz Announces Q3 2026 Results, Strongest Quarterly Revenue and EBITDA Performance in Three Years

  

  PR08:10:00·19m·Consumer DiscretionaryPenny stockHigh short interest

  Hertz Announces Q3 2026 Results, Strongest Quarterly Revenue and EBITDA Performance in Three Years

  "We delivered our strongest quarterly revenue and Adjusted Corporate EBITDA performance in three years, driven by continued revenue growth and margin expansion on flat capacity," said Gil West, Chief Executive Officer of Hertz. "The underlying progress in our core U.S. rental business is meaningful, and we see significant opportunity ahead as we continue to improve execution, expand our franchise model and build new sources of earnings and value across the Hertz platform." Hertz Global Holdings, Inc. (NASDAQ:HTZ) ("Hertz," "Hertz Global," or the "Company") today reported results for its third quarter 2026. Q3 2026 HIGHLIGHTS Revenue totaled $2.6 billion in the third quarter, up appro

  $HTZ
• Maris-Tech Announces Preliminary Gross Revenue Forecast For 2026 in Excess of $5,000,000

  

  PR08:10:00·19m·TelecommunicationsPenny stock

  Maris-Tech Announces Preliminary Gross Revenue Forecast For 2026 in Excess of $5,000,000

  Demand for the Company's defense and AI-powered solutions is expected to increase gross revenues by at least 272% compared to the previous year

  $MTEK
• Annovis Announces Pricing of $21.0 Million Public Offering

  

  PR08:05:34·23m·Health CareOfferingLow floatPenny stock

  Annovis Announces Pricing of $21.0 Million Public Offering

  Annovis Bio, Inc. (NYSE:ANVS) ("Annovis" or the "Company"), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), today announced the pricing of an underwritten public offering of (i) 19,000,000 shares of its common stock and, in lieu of common stock to certain investors that so chose, pre-funded warrants (the "Pre-Funded Warrants") to purchase up to 2,000,000 shares of its common stock, and (ii) accompanying warrants to purchase up to 21,000,000 shares of common stock. The combined offering price of

  $ANVS
• ONCOR REPORTS THIRD QUARTER 2026 RESULTS

  

  PR08:05:00·24m·Utilities

  ONCOR REPORTS THIRD QUARTER 2026 RESULTS

  Oncor Electric Delivery Company LLC ("Oncor") today reported net income of $572 million for the three months ended September 30, 2026, compared to net income of $380 million in the three months ended September 30, 2025. The increase in net income of $192 million was driven by overall higher revenues primarily attributable to higher revenues due to new base rates that went into effect on June 1, 2026, an increase in other regulated revenues recognized related to the Unified Tracker Mechanism ("UTM") and the System Resiliency Plan ("SRP"), higher customer consumption, primarily attributable to warmer weather, revenues recognized in connection with the surch

  $SRE
• Robert Half promotes David King to lead Executive Search across the Americas and Europe

  

  PR08:05:00·24m·Consumer DiscretionaryHigh short interest

  Robert Half promotes David King to lead Executive Search across the Americas and Europe

  Robert Half (NYSE:RHI) has promoted David King to President of Executive Search for the Americas and Europe. In this role, he will lead the company's Executive Search business across the U.S., Canada, South America and Europe, with a focus on driving how organizations find and hire C-suite and senior-level leaders. Since joining Robert Half in 1995, King has held increasingly senior leadership roles across Eastern and Western Canada, Brazil, and Chile, most recently serving as Senior Managing Director for Canada and South America. Over the past 3 decades, he has led operations, d

  $RHI
• Orion Digital Reports Q3 2026 Results; Raises Full-Year Adjusted EBITDA Guidance to $7–8 Million

  

  PR08:05:00·24m·FinancePenny stock

  Orion Digital Reports Q3 2026 Results; Raises Full-Year Adjusted EBITDA Guidance to $7–8 Million

  European Payments Volume of $3.0 Billion, up 7% Year-over-Year Revenue from Wealth and Payments Grows 14% and Represents 41% of Total Revenue Q3 Operating Cash Flow of $2.5 Million Orion Digital reports in Canadian dollars and in accordance with IFRS Accounting Standards. Orion Digital Corp. (NASDAQ:ORIO, TSX:ORIO) ("Orion Digital" or the "Company") today reported financial results for the third quarter ended September 30, 2026. Orion Digital operates a Canadian consumer financial services platform encompassing its Intelligent Investing wealth platform and Mogo Lending, alongside Carta Worldwide, its European payments infrastructure business. Intelligent Investing is the Company’s

  $ORIO
• BlackRock TCP Capital Corp. Announces Third Quarter 2026 Financial Results Including Net Investment Income of $0.16 Per Share; Declares a Fourth Quarter Dividend of $0.17 Per Share

  

  PR08:05:00·24m·FinancePenny stock

  BlackRock TCP Capital Corp. Announces Third Quarter 2026 Financial Results Including Net Investment Income of $0.16 Per Share; Declares a Fourth Quarter Dividend of $0.17 Per Share

  BlackRock TCP Capital Corp. ("we," "us," "our," "TCPC" or the "Company"), a business development company (NASDAQ:TCPC), today announced its financial results for the third quarter ended September 30, 2026 and filed its Form 10-Q with the U.S. Securities and Exchange Commission. FINANCIAL HIGHLIGHTS On a GAAP basis, net investment income for the quarter ended September 30, 2026 was $13.4 million, or $0.16 per share on a diluted basis, which did not exceed the regular dividend of $0.17 per share paid on September 30, 2026. Adjusted net investment income(1) for the quarter ended September 30, 2026 was $12.5 million, or $0.15 per share on a diluted basis. Net decrease in net assets from

  $TCPC
• Genius Group, FingerMotion and BlueFlare Sign Second Binding Agreement for Up to 100 MW Brooks Corridor HPC Campus Program in Alberta

  

  

  PR08:05:00·24m·TechnologyPenny stockInsider buying

  Genius Group, FingerMotion and BlueFlare Sign Second Binding Agreement for Up to 100 MW Brooks Corridor HPC Campus Program in Alberta

  Further to last week’s joint announcement to launch GENIUSpark Alberta targeting an initial 100 MW of high-performance computing (HPC), Genius Group, FingerMotion and BlueFlare signed a binding agreement for a second 100 MW HPC project. FingerMotion and BlueFlare have already received non-binding indications of interest from potential offtakers for up to 52.5 MW of capacity. First site, Brooks Campus No. 1, is a permitted 9.9 MW campus near Tilley in the County of Newell, with powered land expected to be available in the first quarter of 2027. The partners also announced today a non-binding expression of interest with the first offtake customer for up to 7MW AI/HPC Colocation Capacity at

  $GNS$FNGR
• Charles River Associates (CRA) Reports Financial Results for the Third Quarter of 2026

  

  PR08:05:00·24m·Consumer Discretionary

  Charles River Associates (CRA) Reports Financial Results for the Third Quarter of 2026

  Broad-based Revenue Growth Drives Company’s Best-Ever Third-Quarter Results Company Increases Revenue Guidance and Narrows Profit Margin Guidance Range for Full-Year Fiscal 2026 Company Increases Quarterly Dividend by 17.5% Charles River Associates (NASDAQ:CRAI), a worldwide leader in providing economic, financial and management consulting services, today announced financial results for the fiscal third quarter ended October 3, 2026. "CRA continues to build on its strong start to fiscal 2026 as third-quarter revenue increased 15.6% year over year to $214.9 million," said Paul Maleh, CRA’s President and Chief Executive Officer. "This record top-line performance translated into the hi

  $CRAI